Philip L. Hodges's Insider Trades & SAST Disclosures

Philip L. Hodges's most recent trade in Altimmune Inc was a trade of 34,900 Stock Options (option to buy) done . Disclosure was reported to the exchange on Sept. 26, 2024.

Share

Note

This is a custom search result for pattern Philip L. Hodges.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Altimmune Inc	Philip L. Hodges	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Sep 2024	34,900	34,900	-		-	Stock Options (option to buy)
Altimmune Inc	Philip L. Hodges	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Sep 2023	26,100	26,100	-		-	Stock Options (option to buy)
Altimmune Inc	Philip L. Hodges	Director	Sale of securities on an exchange or to another person at price $ 16.08 per share.	01 Mar 2021	6,000	8,731 (0%)	0%	16.1	96,480	Common Stock, par value $0.0001
Altimmune Inc	Philip L. Hodges	Director	Sale of securities on an exchange or to another person at price $ 12.00 per share.	30 Nov 2020	2,500	14,731 (0%)	0%	12	30,000	Common Stock, par value $0.0001
Altimmune Inc	Philip L. Hodges	Director	Sale of securities on an exchange or to another person at price $ 13.54 per share.	30 Nov 2020	1,227	0 (0%)	0%	13.5	16,614	Common Stock, par value $0.0001
Altimmune Inc	Philip L. Hodges	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Sep 2020	25,500	25,500	-		-	Stock Options (option to buy)
Altimmune Inc	Philip L. Hodges	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Sep 2020	16,850	36,306 (0%)	0%		0	Common Stock, par value $0.0001
Altimmune Inc	Philip L. Hodges	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Sep 2020	16,850	0	-		-	Restricted Stock Units ("RSUs")

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades